Give us a call today! 225-767-4893

Clinical research is medical research that benefits people like you.

Patients who meet certain criteria volunteer to participate in carefully conducted investigations that discover better ways to treat, prevent, diagnose, and understand human disease – including Chronic Kidney Disease. Here at Frenova Baton Rouge, we specialize in Renal research.

Our team is focused on supporting our research patients while advancing renal care. All research studies are approved by the FDA and are continuously monitored by the IRB - a group unconnected to the research team that reviews each study to ensure patient rights, safety standards and protocol. Not only do participants help us improve and advance kidney treatment, they often become more knowledgeable and engaged in their own kidney care.  

To learn more about our current studies call 225-329-1529 to reach our clinical research team.

In 2018, Renal Associates partnered with Frenova Renal Research.

Frenova, part of Fresenius Medical Care North America (FMCNA), is a team of renal research experts that operate at the convergence of clinical research and renal patient care. No other clinical development services provider works with a more intimate understanding of patients affected by kidney disease and its comorbid conditions than we do. Frenova provides access to the largest renal research site network in the world.

Our Baton Rouge site is led by Principal Investigator Dr. Michael Roppolo, who explains that “By allowing Frenova to direct the clinical research staff and trial operations, we can enroll more patients into studies and ultimately help patients by introducing new advances and treatments to the market.”

Frenova Baton Rouge is a member of the Frenova F1RST Up alliance, a highly select group of sites chosen for their expertise in renal research and track record of rapid patient recruitment and retention.

Since Frenova has partnered with Renal Associates, we have tripled in size, in staff and research studies that are offered. We look forward to benefitting our patients in the years to come!

Research studies for Patients on Dialysis

 

  • CSL Behring – Clazakizumab - NCT05485961
    • https://clinicaltrials.gov/study/NCT05485961?term=CSL300_2301&rank=1
    • A phase 3, randomized, Double-Blind, study that aims to assess the efficacy of CSL300 on cardiovascular (CV) outcomes and safety in subjects with systemic inflammation and either atherosclerotic cardiovascular disease (ASCVD) or diabetes with end stage kidney disease (ESKD) undergoing maintenance dialysis.
  • Alebund – AP301 - NCT06933472

Research Studies for Patients with Chronic Kidney Disease

 

We look forward to being part of your healthcare team!

Renal Associates is the largest nephrology-specific practice in Louisiana. We are dedicated to providing excellent patient care and work hard to stay on the forefront of cutting-edge medical technology.

Get In Touch

Fill out our contact form below and a representative will be in touch.
Fill out my online form.
Staff Login